Program Schedule

Skip to Day 2

Time	Track 1	Track 2
	DAY 1, May 24
7:00 AM	Registration, Exhibition and Networking Breakfast provided
8:00 AM	Opening Words Ralph Snyderman, Duke University Tal Behar, PMWC Intl Geoff Ginsburg, Duke University Mary E. Klotman, Duke University School of Medicine Roy Cooper, Governor, NC
Sessions:	An Update on All of Us (PMI)
8:45 AM	Francis Collins, NIH (Federal)
9:15 AM	Geoff Ginsburg, Duke University (State)
Sessions:	Status Quo of Genome Sequencing in Cancer & Beyond	Automating Evidence-based Gene Panel Design
9:30 AM	Charles M. Perou, GeneCentric Diagnostics Sequencing Studies for Gene Expression Analysis	Mark J. Kiel, Genomenon Victor Weigman, Q² Solutions
9:45 AM	Vandana Shashi, Duke University School of Medicine Undiagnosed Diseases: Resolving one Diagnosis at a Time	Session continued
10:00 AM	Break, Exhibition and Networking Coffee and Refreshments Provided	Break, Exhibition and Networking Coffee and Refreshments Provided
Sessions:	Informed Health Decisions Through Creating a Learning Ecosystem	Cancer Immunotherapy
10:30 AM	Kenneth J. Pienta, Johns Hopkins University Opening words by session chair Scott L. Zeger, Johns Hopkins University Hopkins inHealth: A Model for Individualized Healthcare	Charles Nicolette, Argos Therapeutics
10:45 AM	Ballentine Carter, Johns Hopkins University Active Surveillance: Individualizing Prostate Cancer Care	Alexis Borisy , Third Rock Ventures Putting the Precision Oncology and I/O Pieces Together
Sessions:	Recent Developments in Cancer Immunology & Immuno-therapy	IT Solutions in Support of Molecular and Genetics Labs
11:00 AM	Chris Boshoff, Pfizer Cancer Immuno-therapy: Science Driving Combinatorial Strategies	Chris Callahan, Sunquest Paul Lang, MedCompGx
11:15 AM	Matthias Gromeier, Duke University Medical Center Cancer Immuno-therapy with Oncolytic Poliovirus	Session continued
Sessions:	Accelerating Clinical Trials Using Compre-hensive Liquid Biopsy	Value-Based Care Models Increase Patient Outcomes and Lower Healthcare Cost
11:30 AM	Daniel Simon, Guardant Health Opening words by session chair	Stuart Goldberg, Cota Healthcare Inc. Thomas Graf, Horizon BCBSNJ
11:45 AM	John Strickler, Duke Cancer Institute Optimizing the Use of ctDNA to Accelerate Clinical Discoveries	Session continued
12:00 PM	Break, Exhibition and Networking Lunch provided	Break, Exhibition and Networking Lunch provided
Sessions:	Data Science to Advance Precision Medicine	Trends in Compre-hensive Study and Biological Sample Management
1:00PM	Eric Schadt, Icahn School of Medicine Deriving Personalized Health Insights from the Fusion of Molecular and Digital Biomarkers	Andrew Brooks, Bioprocessing Solutions Alliance
1:15 PM	Jeffrey Rogers, IBM	Jennifer A. Cheeseman, Duke University
Sessions:	Metabolomics and its Role in Precision Medicine	Session continued
1:30 PM	John Ryals, Metabolon	Christopher Ianelli, iSpecimen Finding Patients and Specimens to Drive Precision Research
1:45 PM	John Ryals, Metabolon- continued	Podium Presentation: Barrett Bready, Nabsys Whole Genome Mapping… Now in HD
Sessions:	Infrastructure and Computational Tools in Support of Research and Genomic Medicine	Why Subsets are the Practice
2:00 PM	Elaine R. Mardis, Nationwide Children’s Hospital Precision Cancer Genomics	Scott L. Zeger, Johns Hopkins University Opening words by session chair
2:15 PM	Stacey Gabriel, Broad Institute of MIT and Harvard To the Cloud(s): Keeping up with DNA Sequencing	Antony Rosen, Johns Hopkins Medicine Rheumatic Disease Autoantibodies: Precision Medicine’s Rosetta Stone
Sessions:	Mobile Health is Changing Healthcare	A Discussion on Increasing Patient Access To Investigational Drugs
2:30 PM	Eric Perakslis, Takeda Pharma Strategies for Delivering Value from Digital Technology Transformation	Moderator: Ralph Snyderman, Duke University Ellen V. Sigal, Friends of Cancer Research Patient Advocacy Role in the Development of the 21 Century Cures Act
2:45 PM	John David Nolen, Cerner Corporation The Role of Interoperability of Patient Data in Precision Medicine	Marty Tenenbaum, Cancer Commons Is An Additional Path to FDA Approval Possible
3:00 PM	Break, Exhibition and Networking Coffee and Refreshments Provided	Break, Exhibition and Networking Coffee and Refreshments Provided
Sessions:	Human Genomics is Fuelling Drug Discovery	ME/CFS: The Mysterious Illness Science Has Yet to Unravel
3:30 PM	Rick Dewey, Regeneron Opening words by session chair	Zaher Nahle, Solve ME/CFS Initiative Opening words by session chair
3:45 PM	Lon Cardon, GSK From Genes to Drug Targets	Anthony L. Komaroff, Harvard Medical School
4:00 PM	Michael Murray, Geisinger Medical Center GenomeFIRST and Risk-Based Healthcare	John Nicols, Codexis
4:15 PM	Novel Approaches to Infectious Disease Diagnosis Christopher W. Woods, Duke University Developing Host Response Signatures for Bacterial and Viral Diseases	Q&A
Sessions:	Leaders in Academia and Industry to Foster Biotechnology	Opportunities & Lessons Learned Establishing Precision Medicine Programs in Oncology
4:30 PM	Ralph Snyderman, Duke University Advancing Precision Medicine into Practice: Clinical Models	Fred Ashbury, Viviphi Ltd. Howard L. McLeod, Moffitt Cancer Center
4:45 PM	Moderator: Ralph Snyderman, Duke University Panelists: Randy Woodson, North Carolina State University William Roper, UNC Jack Bailey, GSK Douglas L. Edgeton, North Carolina Biotechnology Center	Session continued
5:00 PM	Session continues	Track 2 Closing of Day 1
5:30 PM	Track 1 Closing of Day 1
Reception:	Award Reception
6:00 PM	Networking, Hors d'ourves and Wine
7:00 PM	Ralph Snyderman, Duke University Opening Words
7:05 PM	Honorees inductions to PMWC Awards: Francis Collins, NIH to PMWC Luminary Award Keith Yamamoto, UCSF to PMWC Luminary Award Elaine R. Mardis, Nationwide Children's Hospital to PMWC Luminary Award Kathy Giusti, Multiple Myeloma Research Foundation to PMWC Pioneer Award Mark Levin, Third Rock Ventures to PMWC Pioneer Award
8:00 PM	Closing of Award Ceremony


	DAY 2, May 25
Time	Track 1
7:00 AM	Registration, Exhibition and Networking Breakfast provided
Sessions:	The Value of Data Sharing
8:00 AM	Moderator: Geoff Ginsburg, Duke University Panelists: Kathy Giusti, Multiple Myeloma Research Foundation William (Bill) Dalton, M2Gen Robert Califf, Duke University Rick Klausner, Grail
8:30 AM	Session continued	Fireside Chat Keith Yamamoto, UCSF
8:45 AM	New Trends and Emerging Technologies Mark Levin, Third Rock Ventures	Nancy Andrews, Duke University
9:00 AM	Mark Levin, Third Rock Ventures- continued	Podium Presentations: India Hook-Barnard, UCSF CIAPM: Accelerating Precision Medicine Advances in California
9:15 AM	John Mikszta, BD Genomics Single Cell Genomics: Emerging Applications	Jane Wilkinson, Broad Genomics Alliance Management Tackling All Challenges from a Single Sample to Large Clinical Studies
9:30 AM	Lawrence David, Duke University The Role of the Human Microbiome	Stephen Lyle, KEW Inc. NGS Testing for Oncology in Community Settings
9:45 AM	Panna Sharma, Cancer Genetics, Inc. How AI is Accelerating and Enabling Precision Oncology	Amrita Pati, Roche Sequencing Solutions Overcoming Key Challenges in Liquid Biopsy
10:00 AM	Break, Exhibition and Networking Coffee and Refreshments Provided	Break, Exhibition and Networking Coffee and Refreshments Provided
Sessions:	Liquid Biopsy is Propelling Cancer Diagnostics Research	Podium Presentations Continued
10:30 AM	Rick Klausner, Grail Industry Overview: Revolutionizing Cancer Screening	Orla O'Hannaidh, Womble Carlyle Sandridge & Rice, LLP The Legal Landscape: Genetic Information and Privacy Laws in the US
10:45 AM	John Beeler, Inivata Opening words by session chair	Jose Castro-Perez, Waters Corporation Mass Spectrometry Advancements in Precision Medicine
11:00 AM	Ed Kim, Levine Cancer Institute ctDNA in the Routine Management of Cancer Patients: Opportunities and Challenges	Call for Oncologists to Learn About Precision Medicine Vincent Miller, Foundation Medicine Opening words by session chair
Sessions:	CRISPR - The Genome Engineering Revolution	Session continued
11:15 AM	Charles Gersbach, Duke University CRISPR Tools for Gene Therapy and Programming Epigenetics	William Edenfield, Greenville Health System
Sessions:	Delivering Precision Oncology in the Genomics Era	Session continued
11:30 AM	Moderator: Rebecca Brandes, Agilent	Boris Pasche, Wake Forest Baptist Health
11:45 AM	Panelists: Jennifer Morrissette, Penn Medicine Nirali Patel, University of North Carolina	Q&A
12:00 PM	Break, Exhibition and Networking Lunch provided	Break, Exhibition and Networking Lunch provided
Sessions:	Advancing Precision Medicine in Oncology: The Molecular Pathologist’s Role	How Patients Can Advance Precision Medicine and Why You Should Care
1:00 PM	Chris Cournoyer, N-of-One Opening words by session chair	Moira Quinn, Charlotte Center City Partners Opening words by session chair
1:15 PM	Anna Berry, CellNetix	Sarah Kerruish, Antidote
Sessions:	Genomics & Precision Medicine in the "Real World"	Session continued
1:30 PM	Jonathan Berg, UNC Taking Genomic Sequencing from Diagnosis to Screening	Kimberly Blackwell, Duke Cancer Institute
1:45 PM	Amy Abernethy, Flatiron Health Clinico-Genomics: What is it and Why do we need it?	Nicole Russell, Stage IV Non-Small Cell Lung Cancer Patient
Sessions:	Why Patient Engagement is Important	Podium Presentations Continued
2:00 PM	Moderator: Frank Ingari, CureForward	Benoit Destenaves, AstraZeneca Approval of the Liquid Biopsy Test for Tagrisso (osimertinib)
2:15 PM	Panelists: Todd Bauer, Sarah Cannon Bernadette Tosti, QuintilesIMS	Edison Hudson, Panaceutics Inc. Beyond Oncology – Data Driven Personalization and Robotics – Potential Impact For Rx Costs
Sessions:	Reforming Clinical Trials	Track 2 Closing of Day 2
2:30 PM	Janet Woodcock, FDA
Sessions:	Reimburse-ments: The Payor Perspective
2:45 PM	Lee Newcomer, UHC What is The Standard of Care for Personalized Medicine?
3:00 PM	Break, Exhibition and Networking Coffee and Refreshments Provided
Sessions:	Approaches towards Understanding and Enhancing Human Longevity
3:30 PM	Brad Perkins, Human Longevity Precision Medicine Approach to Understanding and Enhancing Human Longevity
3:45 PM	Yaniv Erlich, New York Genome Center Understanding Longevity Using 86,000,000 Individuals
4:00 PM	Track 1 Closing of Day 2
4:30 PM	Tour of Metabolon. THE TOUR IS FULL & CLOSED

See Session Themes ->

Time	Track 1	Track 2
	DAY 1, May 24
7:00 AM	Registration, Exhibition and Networking Breakfast provided
8:00 AM	Opening Words Ralph Snyderman, Duke University Tal Behar, PMWC Intl Geoff Ginsburg, Duke University Mary E. Klotman, Duke University School of Medicine Roy Cooper, Governor, NC
Sessions:	An Update on All of Us (PMI)
8:45 AM	Francis Collins, NIH (Federal)
9:15 AM	Geoff Ginsburg, Duke University (State)
Sessions:	Status Quo of Genome Sequencing in Cancer & Beyond	Automating Evidence-based Gene Panel Design
9:30 AM	Charles M. Perou, GeneCentric Diagnostics Sequencing Studies for Gene Expression Analysis	Mark J. Kiel, Genomenon Victor Weigman, Q² Solutions
9:45 AM	Vandana Shashi, Duke University School of Medicine Undiagnosed Diseases: Resolving one Diagnosis at a Time	Session continued
10:00 AM	Break, Exhibition and Networking Coffee and Refreshments Provided	Break, Exhibition and Networking Coffee and Refreshments Provided
Sessions:	Informed Health Decisions Through Creating a Learning Ecosystem	Cancer Immunotherapy
10:30 AM	Kenneth J. Pienta, Johns Hopkins University Opening words by session chair Scott L. Zeger, Johns Hopkins University Hopkins inHealth: A Model for Individualized Healthcare	Charles Nicolette, Argos Therapeutics
10:45 AM	Ballentine Carter, Johns Hopkins University Active Surveillance: Individualizing Prostate Cancer Care	Alexis Borisy , Third Rock Ventures Putting the Precision Oncology and I/O Pieces Together
Sessions:	Recent Developments in Cancer Immunology & Immuno-therapy	IT Solutions in Support of Molecular and Genetics Labs
11:00 AM	Chris Boshoff, Pfizer Cancer Immuno-therapy: Science Driving Combinatorial Strategies	Chris Callahan, Sunquest Paul Lang, MedCompGx
11:15 AM	Matthias Gromeier, Duke University Medical Center Cancer Immuno-therapy with Oncolytic Poliovirus	Session continued
Sessions:	Accelerating Clinical Trials Using Compre-hensive Liquid Biopsy	Value-Based Care Models Increase Patient Outcomes and Lower Healthcare Cost
11:30 AM	Daniel Simon, Guardant Health Opening words by session chair	Stuart Goldberg, Cota Healthcare Inc. Thomas Graf, Horizon BCBSNJ
11:45 AM	John Strickler, Duke Cancer Institute Optimizing the Use of ctDNA to Accelerate Clinical Discoveries	Session continued
12:00 PM	Break, Exhibition and Networking Lunch provided	Break, Exhibition and Networking Lunch provided
Sessions:	Data Science to Advance Precision Medicine	Trends in Compre-hensive Study and Biological Sample Management
1:00PM	Eric Schadt, Icahn School of Medicine Deriving Personalized Health Insights from the Fusion of Molecular and Digital Biomarkers	Andrew Brooks, Bioprocessing Solutions Alliance
1:15 PM	Jeffrey Rogers, IBM	Jennifer A. Cheeseman, Duke University
Sessions:	Metabolomics and its Role in Precision Medicine	Session continued
1:30 PM	John Ryals, Metabolon	Christopher Ianelli, iSpecimen Finding Patients and Specimens to Drive Precision Research
1:45 PM	John Ryals, Metabolon- continued	Podium Presentation: Barrett Bready, Nabsys Whole Genome Mapping… Now in HD
Sessions:	Infrastructure and Computational Tools in Support of Research and Genomic Medicine	Why Subsets are the Practice
2:00 PM	Elaine R. Mardis, Nationwide Children’s Hospital Precision Cancer Genomics	Scott L. Zeger, Johns Hopkins University Opening words by session chair
2:15 PM	Stacey Gabriel, Broad Institute of MIT and Harvard To the Cloud(s): Keeping up with DNA Sequencing	Antony Rosen, Johns Hopkins Medicine Rheumatic Disease Autoantibodies: Precision Medicine’s Rosetta Stone
Sessions:	Mobile Health is Changing Healthcare	A Discussion on Increasing Patient Access To Investigational Drugs
2:30 PM	Eric Perakslis, Takeda Pharma Strategies for Delivering Value from Digital Technology Transformation	Moderator: Ralph Snyderman, Duke University Ellen V. Sigal, Friends of Cancer Research Patient Advocacy Role in the Development of the 21 Century Cures Act
2:45 PM	John David Nolen, Cerner Corporation The Role of Interoperability of Patient Data in Precision Medicine	Marty Tenenbaum, Cancer Commons Is An Additional Path to FDA Approval Possible
3:00 PM	Break, Exhibition and Networking Coffee and Refreshments Provided	Break, Exhibition and Networking Coffee and Refreshments Provided
Sessions:	Human Genomics is Fuelling Drug Discovery	ME/CFS: The Mysterious Illness Science Has Yet to Unravel
3:30 PM	Rick Dewey, Regeneron Opening words by session chair	Zaher Nahle, Solve ME/CFS Initiative Opening words by session chair
3:45 PM	Lon Cardon, GSK From Genes to Drug Targets	Anthony L. Komaroff, Harvard Medical School
4:00 PM	Michael Murray, Geisinger Medical Center GenomeFIRST and Risk-Based Healthcare	John Nicols, Codexis
4:15 PM	Novel Approaches to Infectious Disease Diagnosis Christopher W. Woods, Duke University Developing Host Response Signatures for Bacterial and Viral Diseases	Q&A
Sessions:	Leaders in Academia and Industry to Foster Biotechnology	Opportunities & Lessons Learned Establishing Precision Medicine Programs in Oncology
4:30 PM	Ralph Snyderman, Duke University Advancing Precision Medicine into Practice: Clinical Models	Fred Ashbury, Viviphi Ltd. Howard L. McLeod, Moffitt Cancer Center
4:45 PM	Moderator: Ralph Snyderman, Duke University Panelists: Randy Woodson, North Carolina State University William Roper, UNC Jack Bailey, GSK Douglas L. Edgeton, North Carolina Biotechnology Center	Session continued
5:00 PM	Session continues	Track 2 Closing of Day 1
5:30 PM	Track 1 Closing of Day 1
Reception:	Award Reception
6:00 PM	Networking, Hors d'ourves and Wine
7:00 PM	Ralph Snyderman, Duke University Opening Words
7:05 PM	Honorees inductions to PMWC Awards: Francis Collins, NIH to PMWC Luminary Award Keith Yamamoto, UCSF to PMWC Luminary Award Elaine R. Mardis, Nationwide Children's Hospital to PMWC Luminary Award Kathy Giusti, Multiple Myeloma Research Foundation to PMWC Pioneer Award Mark Levin, Third Rock Ventures to PMWC Pioneer Award
8:00 PM	Closing of Award Ceremony


	DAY 2, May 25
Time	Track 1
7:00 AM	Registration, Exhibition and Networking Breakfast provided
Sessions:	The Value of Data Sharing
8:00 AM	Moderator: Geoff Ginsburg, Duke University Panelists: Kathy Giusti, Multiple Myeloma Research Foundation William (Bill) Dalton, M2Gen Robert Califf, Duke University Rick Klausner, Grail
8:30 AM	Session continued	Fireside Chat Keith Yamamoto, UCSF
8:45 AM	New Trends and Emerging Technologies Mark Levin, Third Rock Ventures	Nancy Andrews, Duke University
9:00 AM	Mark Levin, Third Rock Ventures- continued	Podium Presentations: India Hook-Barnard, UCSF CIAPM: Accelerating Precision Medicine Advances in California
9:15 AM	John Mikszta, BD Genomics Single Cell Genomics: Emerging Applications	Jane Wilkinson, Broad Genomics Alliance Management Tackling All Challenges from a Single Sample to Large Clinical Studies
9:30 AM	Lawrence David, Duke University The Role of the Human Microbiome	Stephen Lyle, KEW Inc. NGS Testing for Oncology in Community Settings
9:45 AM	Panna Sharma, Cancer Genetics, Inc. How AI is Accelerating and Enabling Precision Oncology	Amrita Pati, Roche Sequencing Solutions Overcoming Key Challenges in Liquid Biopsy
10:00 AM	Break, Exhibition and Networking Coffee and Refreshments Provided	Break, Exhibition and Networking Coffee and Refreshments Provided
Sessions:	Liquid Biopsy is Propelling Cancer Diagnostics Research	Podium Presentations Continued
10:30 AM	Rick Klausner, Grail Industry Overview: Revolutionizing Cancer Screening	Orla O'Hannaidh, Womble Carlyle Sandridge & Rice, LLP The Legal Landscape: Genetic Information and Privacy Laws in the US
10:45 AM	John Beeler, Inivata Opening words by session chair	Jose Castro-Perez, Waters Corporation Mass Spectrometry Advancements in Precision Medicine
11:00 AM	Ed Kim, Levine Cancer Institute ctDNA in the Routine Management of Cancer Patients: Opportunities and Challenges	Call for Oncologists to Learn About Precision Medicine Vincent Miller, Foundation Medicine Opening words by session chair
Sessions:	CRISPR - The Genome Engineering Revolution	Session continued
11:15 AM	Charles Gersbach, Duke University CRISPR Tools for Gene Therapy and Programming Epigenetics	William Edenfield, Greenville Health System
Sessions:	Delivering Precision Oncology in the Genomics Era	Session continued
11:30 AM	Moderator: Rebecca Brandes, Agilent	Boris Pasche, Wake Forest Baptist Health
11:45 AM	Panelists: Jennifer Morrissette, Penn Medicine Nirali Patel, University of North Carolina	Q&A
12:00 PM	Break, Exhibition and Networking Lunch provided	Break, Exhibition and Networking Lunch provided
Sessions:	Advancing Precision Medicine in Oncology: The Molecular Pathologist’s Role	How Patients Can Advance Precision Medicine and Why You Should Care
1:00 PM	Chris Cournoyer, N-of-One Opening words by session chair	Moira Quinn, Charlotte Center City Partners Opening words by session chair
1:15 PM	Anna Berry, CellNetix	Sarah Kerruish, Antidote
Sessions:	Genomics & Precision Medicine in the "Real World"	Session continued
1:30 PM	Jonathan Berg, UNC Taking Genomic Sequencing from Diagnosis to Screening	Kimberly Blackwell, Duke Cancer Institute
1:45 PM	Amy Abernethy, Flatiron Health Clinico-Genomics: What is it and Why do we need it?	Nicole Russell, Stage IV Non-Small Cell Lung Cancer Patient
Sessions:	Why Patient Engagement is Important	Podium Presentations Continued
2:00 PM	Moderator: Frank Ingari, CureForward	Benoit Destenaves, AstraZeneca Approval of the Liquid Biopsy Test for Tagrisso (osimertinib)
2:15 PM	Panelists: Todd Bauer, Sarah Cannon Bernadette Tosti, QuintilesIMS	Edison Hudson, Panaceutics Inc. Beyond Oncology – Data Driven Personalization and Robotics – Potential Impact For Rx Costs
Sessions:	Reforming Clinical Trials	Track 2 Closing of Day 2
2:30 PM	Janet Woodcock, FDA
Sessions:	Reimburse-ments: The Payor Perspective
2:45 PM	Lee Newcomer, UHC What is The Standard of Care for Personalized Medicine?
3:00 PM	Break, Exhibition and Networking Coffee and Refreshments Provided
Sessions:	Approaches towards Understanding and Enhancing Human Longevity
3:30 PM	Brad Perkins, Human Longevity Precision Medicine Approach to Understanding and Enhancing Human Longevity
3:45 PM	Yaniv Erlich, New York Genome Center Understanding Longevity Using 86,000,000 Individuals
4:00 PM	Track 1 Closing of Day 2
4:30 PM	Tour of Metabolon. THE TOUR IS FULL & CLOSED

See Session Themes ->

Program Schedule

Skip to Day 2

Time	Track 1	Track 2
	DAY 1, May 24
7:00 AM	Registration, Exhibition and Networking Breakfast provided
8:00 AM	Opening Words Ralph Snyderman, Duke University Tal Behar, PMWC Intl Geoff Ginsburg, Duke University Mary E. Klotman, Duke University School of Medicine Roy Cooper, Governor, NC
Sessions:	An Update on All of Us (PMI)
8:45 AM	Francis Collins, NIH (Federal)
9:15 AM	Geoff Ginsburg, Duke University (State)
Sessions:	Status Quo of Genome Sequencing in Cancer & Beyond	Automating Evidence-based Gene Panel Design
9:30 AM	Charles M. Perou, GeneCentric Diagnostics Sequencing Studies for Gene Expression Analysis	Mark J. Kiel, Genomenon Victor Weigman, Q² Solutions
9:45 AM	Vandana Shashi, Duke University School of Medicine Undiagnosed Diseases: Resolving one Diagnosis at a Time	Session continued
10:00 AM	Break, Exhibition and Networking Coffee and Refreshments Provided	Break, Exhibition and Networking Coffee and Refreshments Provided
Sessions:	Informed Health Decisions Through Creating a Learning Ecosystem	Cancer Immunotherapy
10:30 AM	Kenneth J. Pienta, Johns Hopkins University Opening words by session chair Scott L. Zeger, Johns Hopkins University Hopkins inHealth: A Model for Individualized Healthcare	Charles Nicolette, Argos Therapeutics
10:45 AM	Ballentine Carter, Johns Hopkins University Active Surveillance: Individualizing Prostate Cancer Care	Alexis Borisy , Third Rock Ventures Putting the Precision Oncology and I/O Pieces Together
Sessions:	Recent Developments in Cancer Immunology & Immuno-therapy	IT Solutions in Support of Molecular and Genetics Labs
11:00 AM	Chris Boshoff, Pfizer Cancer Immuno-therapy: Science Driving Combinatorial Strategies	Chris Callahan, Sunquest Paul Lang, MedCompGx
11:15 AM	Matthias Gromeier, Duke University Medical Center Cancer Immuno-therapy with Oncolytic Poliovirus	Session continued
Sessions:	Accelerating Clinical Trials Using Compre-hensive Liquid Biopsy	Value-Based Care Models Increase Patient Outcomes and Lower Healthcare Cost
11:30 AM	Daniel Simon, Guardant Health Opening words by session chair	Stuart Goldberg, Cota Healthcare Inc. Thomas Graf, Horizon BCBSNJ
11:45 AM	John Strickler, Duke Cancer Institute Optimizing the Use of ctDNA to Accelerate Clinical Discoveries	Session continued
12:00 PM	Break, Exhibition and Networking Lunch provided	Break, Exhibition and Networking Lunch provided
Sessions:	Data Science to Advance Precision Medicine	Trends in Compre-hensive Study and Biological Sample Management
1:00PM	Eric Schadt, Icahn School of Medicine Deriving Personalized Health Insights from the Fusion of Molecular and Digital Biomarkers	Andrew Brooks, Bioprocessing Solutions Alliance
1:15 PM	Jeffrey Rogers, IBM	Jennifer A. Cheeseman, Duke University
Sessions:	Metabolomics and its Role in Precision Medicine	Session continued
1:30 PM	John Ryals, Metabolon	Christopher Ianelli, iSpecimen Finding Patients and Specimens to Drive Precision Research
1:45 PM	John Ryals, Metabolon- continued	Podium Presentation: Barrett Bready, Nabsys Whole Genome Mapping… Now in HD
Sessions:	Infrastructure and Computational Tools in Support of Research and Genomic Medicine	Why Subsets are the Practice
2:00 PM	Elaine R. Mardis, Nationwide Children’s Hospital Precision Cancer Genomics	Scott L. Zeger, Johns Hopkins University Opening words by session chair
2:15 PM	Stacey Gabriel, Broad Institute of MIT and Harvard To the Cloud(s): Keeping up with DNA Sequencing	Antony Rosen, Johns Hopkins Medicine Rheumatic Disease Autoantibodies: Precision Medicine’s Rosetta Stone
Sessions:	Mobile Health is Changing Healthcare	A Discussion on Increasing Patient Access To Investigational Drugs
2:30 PM	Eric Perakslis, Takeda Pharma Strategies for Delivering Value from Digital Technology Transformation	Moderator: Ralph Snyderman, Duke University Ellen V. Sigal, Friends of Cancer Research Patient Advocacy Role in the Development of the 21 Century Cures Act
2:45 PM	John David Nolen, Cerner Corporation The Role of Interoperability of Patient Data in Precision Medicine	Marty Tenenbaum, Cancer Commons Is An Additional Path to FDA Approval Possible
3:00 PM	Break, Exhibition and Networking Coffee and Refreshments Provided	Break, Exhibition and Networking Coffee and Refreshments Provided
Sessions:	Human Genomics is Fuelling Drug Discovery	ME/CFS: The Mysterious Illness Science Has Yet to Unravel
3:30 PM	Rick Dewey, Regeneron Opening words by session chair	Zaher Nahle, Solve ME/CFS Initiative Opening words by session chair
3:45 PM	Lon Cardon, GSK From Genes to Drug Targets	Anthony L. Komaroff, Harvard Medical School
4:00 PM	Michael Murray, Geisinger Medical Center GenomeFIRST and Risk-Based Healthcare	John Nicols, Codexis
4:15 PM	Novel Approaches to Infectious Disease Diagnosis Christopher W. Woods, Duke University Developing Host Response Signatures for Bacterial and Viral Diseases	Q&A
Sessions:	Leaders in Academia and Industry to Foster Biotechnology	Opportunities & Lessons Learned Establishing Precision Medicine Programs in Oncology
4:30 PM	Ralph Snyderman, Duke University Advancing Precision Medicine into Practice: Clinical Models	Fred Ashbury, Viviphi Ltd. Howard L. McLeod, Moffitt Cancer Center
4:45 PM	Moderator: Ralph Snyderman, Duke University Panelists: Randy Woodson, North Carolina State University William Roper, UNC Jack Bailey, GSK Douglas L. Edgeton, North Carolina Biotechnology Center	Session continued
5:00 PM	Session continues	Track 2 Closing of Day 1
5:30 PM	Track 1 Closing of Day 1
Reception:	Award Reception
6:00 PM	Networking, Hors d'ourves and Wine
7:00 PM	Ralph Snyderman, Duke University Opening Words
7:05 PM	Honorees inductions to PMWC Awards: Francis Collins, NIH to PMWC Luminary Award Keith Yamamoto, UCSF to PMWC Luminary Award Elaine R. Mardis, Nationwide Children's Hospital to PMWC Luminary Award Kathy Giusti, Multiple Myeloma Research Foundation to PMWC Pioneer Award Mark Levin, Third Rock Ventures to PMWC Pioneer Award
8:00 PM	Closing of Award Ceremony


	DAY 2, May 25
Time	Track 1
7:00 AM	Registration, Exhibition and Networking Breakfast provided
Sessions:	The Value of Data Sharing
8:00 AM	Moderator: Geoff Ginsburg, Duke University Panelists: Kathy Giusti, Multiple Myeloma Research Foundation William (Bill) Dalton, M2Gen Robert Califf, Duke University Rick Klausner, Grail
8:30 AM	Session continued	Fireside Chat Keith Yamamoto, UCSF
8:45 AM	New Trends and Emerging Technologies Mark Levin, Third Rock Ventures	Nancy Andrews, Duke University
9:00 AM	Mark Levin, Third Rock Ventures- continued	Podium Presentations: India Hook-Barnard, UCSF CIAPM: Accelerating Precision Medicine Advances in California
9:15 AM	John Mikszta, BD Genomics Single Cell Genomics: Emerging Applications	Jane Wilkinson, Broad Genomics Alliance Management Tackling All Challenges from a Single Sample to Large Clinical Studies
9:30 AM	Lawrence David, Duke University The Role of the Human Microbiome	Stephen Lyle, KEW Inc. NGS Testing for Oncology in Community Settings
9:45 AM	Panna Sharma, Cancer Genetics, Inc. How AI is Accelerating and Enabling Precision Oncology	Amrita Pati, Roche Sequencing Solutions Overcoming Key Challenges in Liquid Biopsy
10:00 AM	Break, Exhibition and Networking Coffee and Refreshments Provided	Break, Exhibition and Networking Coffee and Refreshments Provided
Sessions:	Liquid Biopsy is Propelling Cancer Diagnostics Research	Podium Presentations Continued
10:30 AM	Rick Klausner, Grail Industry Overview: Revolutionizing Cancer Screening	Orla O'Hannaidh, Womble Carlyle Sandridge & Rice, LLP The Legal Landscape: Genetic Information and Privacy Laws in the US
10:45 AM	John Beeler, Inivata Opening words by session chair	Jose Castro-Perez, Waters Corporation Mass Spectrometry Advancements in Precision Medicine
11:00 AM	Ed Kim, Levine Cancer Institute ctDNA in the Routine Management of Cancer Patients: Opportunities and Challenges	Call for Oncologists to Learn About Precision Medicine Vincent Miller, Foundation Medicine Opening words by session chair
Sessions:	CRISPR - The Genome Engineering Revolution	Session continued
11:15 AM	Charles Gersbach, Duke University CRISPR Tools for Gene Therapy and Programming Epigenetics	William Edenfield, Greenville Health System
Sessions:	Delivering Precision Oncology in the Genomics Era	Session continued
11:30 AM	Moderator: Rebecca Brandes, Agilent	Boris Pasche, Wake Forest Baptist Health
11:45 AM	Panelists: Jennifer Morrissette, Penn Medicine Nirali Patel, University of North Carolina	Q&A
12:00 PM	Break, Exhibition and Networking Lunch provided	Break, Exhibition and Networking Lunch provided
Sessions:	Advancing Precision Medicine in Oncology: The Molecular Pathologist’s Role	How Patients Can Advance Precision Medicine and Why You Should Care
1:00 PM	Chris Cournoyer, N-of-One Opening words by session chair	Moira Quinn, Charlotte Center City Partners Opening words by session chair
1:15 PM	Anna Berry, CellNetix	Sarah Kerruish, Antidote
Sessions:	Genomics & Precision Medicine in the "Real World"	Session continued
1:30 PM	Jonathan Berg, UNC Taking Genomic Sequencing from Diagnosis to Screening	Kimberly Blackwell, Duke Cancer Institute
1:45 PM	Amy Abernethy, Flatiron Health Clinico-Genomics: What is it and Why do we need it?	Nicole Russell, Stage IV Non-Small Cell Lung Cancer Patient
Sessions:	Why Patient Engagement is Important	Podium Presentations Continued
2:00 PM	Moderator: Frank Ingari, CureForward	Benoit Destenaves, AstraZeneca Approval of the Liquid Biopsy Test for Tagrisso (osimertinib)
2:15 PM	Panelists: Todd Bauer, Sarah Cannon Bernadette Tosti, QuintilesIMS	Edison Hudson, Panaceutics Inc. Beyond Oncology – Data Driven Personalization and Robotics – Potential Impact For Rx Costs
Sessions:	Reforming Clinical Trials	Track 2 Closing of Day 2
2:30 PM	Janet Woodcock, FDA
Sessions:	Reimburse-ments: The Payor Perspective
2:45 PM	Lee Newcomer, UHC What is The Standard of Care for Personalized Medicine?
3:00 PM	Break, Exhibition and Networking Coffee and Refreshments Provided
Sessions:	Approaches towards Understanding and Enhancing Human Longevity
3:30 PM	Brad Perkins, Human Longevity Precision Medicine Approach to Understanding and Enhancing Human Longevity
3:45 PM	Yaniv Erlich, New York Genome Center Understanding Longevity Using 86,000,000 Individuals
4:00 PM	Track 1 Closing of Day 2
4:30 PM	Tour of Metabolon. THE TOUR IS FULL & CLOSED

See Session Themes ->

Program Schedule

Program Schedule

Trouble Registering

Contact PMWC